DRL launches generic version of Adcirca

Dr. Reddy’s Laboratories (DRL) has launched Tadalafil tablets, a therapeutic equivalent generic version of Adcirca (tadalafil) tablets, in the U.S. market. A trademark of Eli Lilly and Company, Adcirca is used to treat pulmonary arterial hypertension. Stating that the USFDA had approved its generic version, DRL said Tadalafil tablets were available in 20 mg strength and in 60 count bottle size.

Source: Read Full Article